US Patent 11154549 Opioid compositions resistant to overdose and abuse
Patent 11154549 was granted and assigned to Elysium Therapeutics, Inc. on October, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11154549 Opioid compositions resistant to overdose and abuse
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.